Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?

Lancet. 2000 Dec 2;356(9245):1865-6. doi: 10.1016/S0140-6736(00)03251-7.

Authors

C S Graham¹, M J Koziel

Affiliation

¹ Infectious Disease Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

PMID: 11130376
DOI: 10.1016/S0140-6736(00)03251-7

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes / cytology
CD4-Positive T-Lymphocytes / drug effects
CD4-Positive T-Lymphocytes / immunology
HIV Infections / complications
HIV Infections / drug therapy
HIV Infections / immunology*
HIV Infections / virology
HIV-1 / drug effects
Hepatitis C / complications
Hepatitis C / immunology*
Humans

Substances

Antiviral Agents